These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8604507)

  • 21. Seroprevalence of Trypanosoma cruzi in blood donors at the National Blood Transfusion Services--Guyana.
    Bwititi PT; Browne J
    West Indian Med J; 2012 Sep; 61(6):559-63. PubMed ID: 23441347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk of Chagas disease through transfusions in the Americans].
    Schmuñis GA
    Medicina (B Aires); 1999; 59 Suppl 2():125-34. PubMed ID: 10668254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of exposure to Chagas' disease among seroreactive Brazilian blood donors.
    Salles NA; Sabino EC; Cliquet MG; Eluf-Neto J; Mayer A; Almeida-Neto C; Mendonça MC; Dorliach-Llacer P; Chamone DF; Saéz-Alquézar A
    Transfusion; 1996; 36(11-12):969-73. PubMed ID: 8937406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I. Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi.
    Brashear RJ; Winkler MA; Schur JD; Lee H; Burczak JD; Hall HJ; Pan AA
    Transfusion; 1995 Mar; 35(3):213-8. PubMed ID: 7878713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States.
    Kirchhoff LV; Paredes P; Lomelí-Guerrero A; Paredes-Espinoza M; Ron-Guerrero CS; Delgado-Mejía M; Peña-Muñoz JG
    Transfusion; 2006 Feb; 46(2):298-304. PubMed ID: 16441610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion-transmitted Chagas' disease.
    Wendel S
    Curr Opin Hematol; 1998 Nov; 5(6):406-11. PubMed ID: 9814647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood donor screening for chagas disease--United States, 2006-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(7):141-3. PubMed ID: 17318113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for Trypanosoma cruzi infection among blood donors in central Brazil.
    Martelli CM; Andrade AL; Silva SA; Zicker F
    Mem Inst Oswaldo Cruz; 1992; 87(3):339-43. PubMed ID: 1343642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing.
    O'Brien SF; Chiavetta JA; Fan W; Xi G; Yi QL; Goldman M; Scalia V; Fearon MA
    Transfusion; 2008 Apr; 48(4):755-61. PubMed ID: 18194375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors and Screening for Trypanosoma cruzi Infection of Dutch Blood Donors.
    Slot E; Hogema BM; Molier M; Bart A; Zaaijer HL
    PLoS One; 2016; 11(3):e0151038. PubMed ID: 26950434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection.
    Leiby DA; Herron RM; Garratty G; Herwaldt BL
    J Infect Dis; 2008 Aug; 198(4):609-13. PubMed ID: 18588482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission.
    Leiby DA; Fucci MH; Stumpf RJ
    Transfusion; 1999 Mar; 39(3):310-5. PubMed ID: 10204596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chagas' disease: lessons from routine donation testing.
    Castro E
    Transfus Med; 2009 Feb; 19(1):16-23. PubMed ID: 19302451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negligible prevalence of antibodies against Trypanosoma cruzi among blood donors in the southeastern United States.
    Barrett VJ; Leiby DA; Odom JL; Otani MM; Rowe JD; Roote JT; Cox KF; Brown KR; Hoiles JA; Saez-Alquézar A; Turrens JF
    Am J Clin Pathol; 1997 Nov; 108(5):499-503. PubMed ID: 9353087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood donors in a vector-free zone of Ecuador potentially infected with Trypanosoma cruzi.
    Grijalva MJ; Rowland EC; Powell MR; McCormick TS; Escalante L
    Am J Trop Med Hyg; 1995 Apr; 52(4):360-3. PubMed ID: 7741178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission.
    Benjamin RJ; Stramer SL; Leiby DA; Dodd RY; Fearon M; Castro E
    Transfusion; 2012 Sep; 52(9):1913-21; quiz 1912. PubMed ID: 22321142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood transfusion and iatrogenic risks in Mexico City. Anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive.
    Hernández-Becerril N; Mejía AM; Ballinas-Verdugo MA; Garza-Murillo V; Manilla-Toquero E; López R; Trevethan S; Cardenas M; Reyes PA; Hirayama K; Monteón VM
    Mem Inst Oswaldo Cruz; 2005 Apr; 100(2):111-6. PubMed ID: 16021296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of one-time testing for Trypanosoma cruzi antibodies among blood donors in the United States.
    Dodd RY; Groves JA; Townsend RL; Notari EP; Foster GA; Custer B; Busch MP; Stramer SL
    Transfusion; 2019 Mar; 59(3):1016-1023. PubMed ID: 30588627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Why defer blood donor candidates because of an exposure risk to Chagas disease?].
    Garraud O; Pelletier B; Aznar C
    Transfus Clin Biol; 2008 Jun; 15(3):123-8. PubMed ID: 18620885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukoreduction by centrifugation does not eliminate Trypanosoma cruzi from infected blood units.
    Dzib D; Hernández VP; Ake BC; López RA; Monteón VM
    Vector Borne Zoonotic Dis; 2009 Jun; 9(3):235-41. PubMed ID: 19485765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.